Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the women's interagency HIV study [2]

Journal of Alternative and Complementary Medicine

Volumn 13, Issue 10, 2007, Pages 1053-1056

  Liu, Chenglong ^a   Lerch, Virginia ^b   Weber, Kathleen ^c   Schneider, Michael F ^d   Sharp, Gerald B ^e   Gorapaju, Lakshmi ^a   Sharma, Anjali ^f   Levine, Alexandra ^g   Gandhi, Monica ^h   Merenstein, Daniel ⁱ  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c Jr Hospital of Cook County   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ANTIRETROVIRUS AGENT; FOLIC ACID; MULTIVITAMIN;

ALTERNATIVE MEDICINE; CHIROPRACTIC; EXERCISE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; UNITED STATES; WOMEN'S HEALTH;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMPLEMENTARY THERAPIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; QUALITY OF LIFE; SOCIAL SUPPORT; WOMEN'S HEALTH;

EID: 37649018338     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2007.0590     Document Type: Letter

References (15)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Schneider MF, Gange SJ, Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS 2005;19:2009-2018.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
4. Malone SB, Osborne JJ. Improving treatment adherence in drug abusers who are HIV-positive. Lippincotts Case Manag 2000;5:236-245; quiz 245-237.
5. Owen-Smith A, Diclemente R, Wingood G. Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women. AIDS Care 2007;19:589-593.
6. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9:117-125.
7. DHHS/Henry J. Kaiser family foundation panel on clinical practices for the treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. April 2005 revision. Online document at: http://aidsinfo.nih.gov Accessed March 1, 2007.
8. Diggle PJ HP, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford: Oxford University Press, 2002.
9. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-733.
10. Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2005;38:320-328.
11. Wilson TE, Barron Y, Cohen M, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002;34:529-534.
12. Parsons SK, Cruise PL, Davenport WM, Jones V. Religious beliefs, practices and treatment adherence among individuals with HIV in the southern United States. AIDS Patient Care STDS 2006;20:97-111.
13. Furler MD, Einarson TR, Walmsley S, et al. Polypharmacy in HIV: Impact of data source and gender on reported drug utilization. AIDS Patient Care STDS 2004;18:568-586.
14. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007;146:564-573.
15. Shuter J, Sarlo JA, Kanmaz TJ, et al. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr 2007;45:4-8.